42nd Parliament, 1st Session
(December 3, 2015 - September 11, 2019)
M-132, Federally Funded Health Research
Report and Government Response
Report 20:
Towards Open Science: Promoting Innovation in Pharmaceutical Research and Development and Access to Affordable Medications both in Canada and Abroad
- Adopted by the Committee: November 8, 2018
- Presented to the House: November 26, 2018
Information
That the Standing Committee on Health be instructed to undertake a study on ways of increasing benefits to the public resulting from federally funded health research, with the goals of lowering drugs costs and increasing access to medicines, both in Canada and globally; and that the Committee report its findings and recommendations to the House no later than one year from the time this motion is adopted
